ASRS President Reflects on a Year of Change

• by Geoffrey G. Emerson, MD, PhD, FASRS

• July 15, 2026

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

• by Kerri Miller

• May 7, 2026

• 3 min

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

• by Kathryn Wighton

• May 13, 2026

• 5 min

Connecting Structure and Function in GA

Post hoc GATHER2 analyses presented at ASRS 2026 suggest ellipsoid zone integrity and low-luminance deficit may provide complementary measures of disease progression and treatment response.

• by Jim Gallagher, senior managing editor

• July 1, 2026

• 3 min